• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功的人类免疫缺陷病毒治疗结果的决定因素:马来西亚国家数据源的关联

Determinants of Successful Human Immunodeficiency Virus Treatment Outcomes: A Linkage of National Data Sources in Malaysia.

作者信息

Wan Mohamad Darani Wan Nur Syamimi, Chen Xin Wee, Samsudin Ely Zarina, Mohd Nor Fadzilah, Ismail Ismawati

机构信息

Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia.

HIV Unit, Kuala Lumpur and Putrajaya Federal Territories Health Department (JKWPKLP), Ministry of Health, Kuala Lumpur, Malaysia.

出版信息

Malays J Med Sci. 2023 Feb;30(1):172-184. doi: 10.21315/mjms2023.30.1.15. Epub 2023 Feb 28.

DOI:10.21315/mjms2023.30.1.15
PMID:36875201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984112/
Abstract

BACKGROUND

Concerted efforts have been undertaken to reduce the human immunodeficiency virus (HIV) infection by the year 2030 in Malaysia. A situational analysis of the performance of successful HIV treatment and its determinants is vital; however, this information remains scarce. This study aimed to identify the determinants of undetectable viral load among people living with HIV (PLHIV).

METHODS

Newly diagnosed HIV cases ( = 493) registered under the Malaysia HIV/AIDS-related national databases from June 2018 to December 2019 were studied. The deterministic matching method was applied to link the records in two national databases (at Kuala Lumpur and Putrajaya Federal Territories Health Department, JKWPKLP HIV line-listing database and National AIDS Registry). Successful HIV treatment, an outcome variable, was measured by the undetectable viral load < 200 copies/mL after 1 year of antiretroviral therapy initiation. Logistic regression analysis was applied in the current study.

RESULTS

Results showed that 454/493 (92.2%; 95% confidence interval [CI]: 89.8%, 94.6%) PLHIV had successful HIV treatment. Study participants had a mean (SD) age of 30 (8.10) years old, predominantly male (96.1%) and sexually transmission (99.9%). The multiple logistic regression analysis revealed two significant determinants including the timing of ART initiation (AOR = 3.94; 95% CI: 1.32, 11.70; = 0.014) and establishment of Sexually Transmitted Infection Friendly Clinic (STIFC) (AOR = 3.40; 95% CI: 1.47, 7.85; = 0.004). Non-significant variables included gender, education level, HIV risk exposure, and co-infections of tuberculosis and Hepatitis C.

CONCLUSION

JKWPKLP is on the right track to achieving universal treatment as a prevention strategy. Reinforcement of early ART initiation and establishment of STIFC are recommended.

摘要

背景

马来西亚已齐心协力在2030年前减少人类免疫缺陷病毒(HIV)感染。对成功的HIV治疗表现及其决定因素进行现状分析至关重要;然而,此类信息仍然匮乏。本研究旨在确定HIV感染者(PLHIV)中病毒载量不可检测的决定因素。

方法

对2018年6月至2019年12月在马来西亚HIV/AIDS相关国家数据库中登记的新诊断HIV病例(n = 493)进行研究。采用确定性匹配方法将两个国家数据库(吉隆坡和布城联邦直辖区卫生部、JKWPKLP HIV病例清单数据库和国家艾滋病登记处)中的记录相链接。成功的HIV治疗作为一个结果变量,通过抗逆转录病毒治疗开始1年后病毒载量<200拷贝/mL不可检测来衡量。本研究应用了逻辑回归分析。

结果

结果显示,454/493(92.2%;95%置信区间[CI]:89.8%,94.6%)的PLHIV获得了成功的HIV治疗。研究参与者的平均(标准差)年龄为30(8.10)岁,主要为男性(96.1%)且通过性传播(99.9%)。多元逻辑回归分析揭示了两个重要的决定因素,包括开始抗逆转录病毒治疗的时机(调整后比值比[AOR]=3.94;95%CI:1.32,11.70;P = 0.014)和建立性传播感染友好诊所(STIFC)(AOR = 3.40;95%CI:1.47,7.85;P = 0.004)。无统计学意义的变量包括性别、教育水平、HIV风险暴露以及结核病和丙型肝炎合并感染。

结论

JKWPKLP在实现作为预防策略的普遍治疗方面步入了正轨。建议加强早期抗逆转录病毒治疗的启动并建立STIFC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071e/9984112/48ca83569d8a/mjms3001_art15_oaf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071e/9984112/8576761db15d/mjms3001_art15_oaf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071e/9984112/48ca83569d8a/mjms3001_art15_oaf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071e/9984112/8576761db15d/mjms3001_art15_oaf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/071e/9984112/48ca83569d8a/mjms3001_art15_oaf2.jpg

相似文献

1
Determinants of Successful Human Immunodeficiency Virus Treatment Outcomes: A Linkage of National Data Sources in Malaysia.成功的人类免疫缺陷病毒治疗结果的决定因素:马来西亚国家数据源的关联
Malays J Med Sci. 2023 Feb;30(1):172-184. doi: 10.21315/mjms2023.30.1.15. Epub 2023 Feb 28.
2
Current syphilis infection in virally suppressed people living with HIV: a cross-sectional study in eastern China.中国东部一项横断面研究:病毒抑制的 HIV 感染者现患梅毒感染。
Front Public Health. 2024 Jun 19;12:1366795. doi: 10.3389/fpubh.2024.1366795. eCollection 2024.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia.埃塞俄比亚西部内克梅特转诊医院艾滋病毒感染者中抗逆转录病毒治疗延迟启动的患病率及相关因素
HIV AIDS (Auckl). 2020 Sep 24;12:457-465. doi: 10.2147/HIV.S267408. eCollection 2020.
5
Burden of hepatitis B virus and syphilis co-infections and its impact on HIV treatment outcome in Ethiopia: nationwide community-based study.在埃塞俄比亚,乙型肝炎病毒和梅毒合并感染的负担及其对 HIV 治疗结果的影响:全国社区为基础的研究。
Ann Med. 2023;55(2):2239828. doi: 10.1080/07853890.2023.2239828.
6
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.3岁以下HIV感染儿童抗逆转录病毒疗法的优化
Cochrane Database Syst Rev. 2014 May 22;2014(5):CD004772. doi: 10.1002/14651858.CD004772.pub4.
7
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.开始抗逆转录病毒治疗时人类免疫缺陷病毒(HIV)无症状状态对依从性和治疗结果的作用以及检测和治疗的影响:瑞士艾滋病毒队列研究。
Clin Infect Dis. 2021 Apr 26;72(8):1413-1421. doi: 10.1093/cid/ciaa239.
8
[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].[西班牙艾滋病研究与治疗协作组/国家艾滋病计划关于成人感染人类免疫缺陷病毒抗逆转录病毒治疗的全国共识文件(2011年1月更新)]
Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004.
9
Tuberculosis Treatment Outcome in Patients with TB-HIV Coinfection in Kuala Lumpur, Malaysia.马来西亚吉隆坡合并感染结核与艾滋病病毒患者的结核病治疗结果
J Trop Med. 2021 May 29;2021:9923378. doi: 10.1155/2021/9923378. eCollection 2021.
10
Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.塞纳卡塔纳抗逆转录病毒治疗诊所的抗逆转录病毒治疗方案结局:莱索托四年回顾性队列研究。
Pan Afr Med J. 2023 Nov 2;46:74. doi: 10.11604/pamj.2023.46.74.40122. eCollection 2023.

引用本文的文献

1
Modelling the role of tourism in the spread of HIV: A case study from Malaysia.模拟旅游业在艾滋病毒传播中的作用:以马来西亚为例的案例研究。
Heliyon. 2024 Aug 8;10(16):e35896. doi: 10.1016/j.heliyon.2024.e35896. eCollection 2024 Aug 30.

本文引用的文献

1
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review.在撒哈拉以南非洲地区,通过差异化服务提供模式进行 HIV 治疗时,患者在治疗中的保留率和病毒抑制率:快速系统评价。
J Int AIDS Soc. 2020 Nov;23(11):e25640. doi: 10.1002/jia2.25640.
2
Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.了解乌干达国家扩大差异化抗逆转录病毒治疗服务中的实施障碍。
BMC Health Serv Res. 2020 Mar 17;20(1):222. doi: 10.1186/s12913-020-5069-y.
3
Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
津巴布韦哈拉雷地区 HIV 血清阳性且初始病毒载量较高患者中强化依从性咨询和病毒载量抑制:操作问题。
PLoS One. 2019 Feb 5;14(2):e0211326. doi: 10.1371/journal.pone.0211326. eCollection 2019.
4
Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.柬埔寨感染艾滋病毒青少年中与病毒未被抑制相关的因素:一项横断面研究。
AIDS Res Ther. 2018 Nov 17;15(1):20. doi: 10.1186/s12981-018-0205-z.
5
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.接受抗逆转录病毒治疗的成人和儿童的HIV病毒载量抑制——来自IeDEA合作项目的结果
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):319-329. doi: 10.1097/QAI.0000000000001499.
6
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses.英国接受抗逆转录病毒治疗的艾滋病毒感染者的社会经济状况与治疗结果:横断面和纵向分析
Lancet Public Health. 2016 Nov;1(1):e26-e36. doi: 10.1016/S2468-2667(16)30002-0.
7
Patient Use of Electronic Prescription Refill and Secure Messaging and Its Association With Undetectable HIV Viral Load: A Retrospective Cohort Study.患者使用电子处方续方和安全消息传递及其与无法检测到的艾滋病毒载量的关联:一项回顾性队列研究。
J Med Internet Res. 2017 Feb 15;19(2):e34. doi: 10.2196/jmir.6932.
8
Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis.HIV 诊断后首次就诊即开始抗逆转录病毒治疗者的 HIV 病毒载量快速抑制。
Sci Rep. 2016 Sep 6;6:32947. doi: 10.1038/srep32947.
9
Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam.越南抗逆转录病毒治疗中与 HIV 病毒载量抑制相关的因素。
J Virus Erad. 2016 Apr 1;2(2):94-101. doi: 10.1016/S2055-6640(20)30466-0.
10
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.血清学异性性伴侣中,当 HIV 阳性一方接受抑制性抗反转录病毒治疗时,无保护性行为与 HIV 传播风险
JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148.